Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancer

JHEP Reports(2025)10.1016/j.jhepr.2025.101426Source: DataRank Database

Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancer is a research paper published in JHEP Reports (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (8)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Hao Huang ORCID,Aikha Melissa Go Wong,Howard H.W. Leung ORCID,Winnie Wing Yan Cheung,Yin Kau Lam ORCID

Live enrichment

PubMed:40584266 PMC:PMC12205652

University Grants Committee

Grant: R4017-18

University Grants Committee

Grant: AoE/M-401/20

National Institutes of Health

Grant: R01CA229836

Innovation and Technology Fund

Grant: PRP/073/21FX

National Institutes of Health

Grant: 1R01CA229836-01A1

qHTS of Patient Derived HCC Models to Identify Novel Probes/Therapeutic Agents

Research Grants Council, University Grants Committee

Chinese University of Hong Kong

goldLicense: CC BY NC ND

publisherhttps://doi.org/10.1016/j.jhepr.2025.101426

publisherhttps://api.elsevier.com/content/article/PII:S258955592500103X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S258955592500103X?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12205652

Europe_PMChttps://europepmc.org/articles/PMC12205652

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Synthetic LethalityDrug RepurposingCtnnb1Precision MedicineLiver Cancer OrganoidsResearch Article

Related Papers (5)

Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer

Seminars in Liver Disease(2025)

co-cited

10.1055/a-2551-0724

E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

N/A

0.282DataRank · unranked

Clinical Cancer Research(2025)

co-cited

10.1158/1078-0432.ccr-25-0725

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

N/A

1.3DataRank · unranked

New England Journal of Medicine(2020)

co-cited

10.1056/nejmoa1915745

Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma

Communications Biology(2021)

co-cited

10.1038/s42003-021-02562-8

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

Top 1%

12.6DataRank

Cell(2015)

co-cited

10.1016/j.cell.2015.03.053

Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancer

FAIR Checklist

Authors (16)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (5)